関連する実験動画
Updated: Sep 9, 2025

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
11.6K
ロシアの粘膜糖症登録によると,II型粘膜糖症患者の致死率の分析
Natalia Buchinskaya1,2, Anastasia Vechkasova2, Nato Vashakmadze3,4
1Hospital Pediatry, Saint-Petersburg State Pediatric Medical University, Saint-Petersburg 194100, Sankt-Peterburg, Russia.
World journal of clinical pediatrics
|August 29, 2025
まとめ
ムコポリサカリドーシスII型 (MPSII) の致死性の予測因子には,高出生体重,診断の遅延,歩行障害による神経病状が含まれます. MPS II患者の生存率を向上させるために,早期の介入は極めて重要です.
科学分野:
- 遺伝学と希少疾患
- 小児薬
- メタボリック障害
背景:
- ムコポリサカリドーシスII型 (MPSII) は,複数の臓器に影響を及ぼし,寿命を短くする進行性遺伝疾患です.
- MPSIIは著しい罹病率と死亡率を示しており,患者のアウトカムに影響を与える要因を特定することが必要である.
研究 の 目的:
- ムコポリサカリドーシスII型と診断された患者の死亡と関連した主要な予測要因を特定する.
- 臨床データと人口統計データを分析し,MPSIIにおける死亡率に寄与する要因を理解する.
主な方法:
- ロシアのMPS II登録における約160人の患者のデータを分析した遡及コホート研究.
- 死者と生きているMPS II患者の臨床,実験,および酵素置換療法 (ERT) のデータの比較.
- コックス回帰分析により,時間依存の共変数による致死率を決定する.
主要な成果:
- 死亡原因は主に心血管不全と呼吸器不全であった.
- 死亡した患者は出生時体重が高く,診断時およびERT開始時の年齢が遅く,水頭症,,運動障害の有病率が高かった.
- 死亡率の有意な予測要因には,精神運動の遅延,水頭症,飲み込み障害,12歳以降の歩行不全,呼吸器障害,気管切除,神経疾患が含まれていた.
結論:
- 出生体重増加,診断の遅延,ERT開始の遅延は,MPS IIにおける致命的な結果の重要な予測因子です.
- 特に12歳以降の歩行能力の低下が死亡率の重要な危険因子である.
- これらの発見は,MPS IIの管理と患者の生存率の改善において,早期診断と早期介入の重要性を強調しています.
関連する概念動画
Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Actuarial Approach
132
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
132

